On April 3rd 2020, IPA Europe President Esben Laulund, in the video statement is calling for “a viable probiotic industry” in the European Union. In fact, most of European consumers know what probiotics are, and they are looking for it, but they can find only the products from outside Europe that are offered on e-commerce. ...
On March 17th 2020, the second edition of the Gut Health Summit will take place in Brussels (Belgium). The market situation for Pre- and Probiotics is drastically changing worldwide. The growing knowledge and understanding of the gut microbiome creates many new opportunities. At the same time, Pre- and Probiotics are confronted with legislative restrictions and ...
On 18th February, Rosanna Pecere, Executive Director of IPA Europe, attended the event “Healthier citizens and a stronger economy in the EU”, organised by EHPM in the European Parliament, hosted by Belgian MEP Pascal Arimont and Italian MEP Simona Bonafè. After the keynote speech of the MEP Pascal Arimont (EPP; Belgium), Ms Livia Menichetti, EHPM’s ...
On 18 January 2019, IPA Europe met with the European Food Safety Authority (EFSA) in Parma, Italy, for a scientific discussion. This enabled IPA Europe scientific experts to gain a better understanding of the EFSA role and remit, particularly with regard to scientific substantiation of health claims made on food. A debate also took place ...
On Monday 9th September 2019, Esbend Laulund, President IPA Europe, opened the session “THE GLOBAL VOICE OF PROBIOTICS IPA/IPA EUROPE SESSION: How to define a comprehensive approach for the definition of the probiotic category (nutrition relevance and scientific requirements)”. With the help of the experts, we gathered to discuss issues pertaining to the interplay between ...
The International Scientific Association of Probiotics and Prebiotics (ISAPP), immediately reacted to the recent papers by Zmora, et al and Suez, et al, with scientific arguments to counter the inaccurate information on probiotics: Hundreds of human trials have demonstrated clinical benefits of probiotics and several evidence-based recommendations have been issued by medical organizations. This irresponsible ...
It is regrettable that, although the authors themselves state that the microbiota is influenced by very many factors and is extremely diverse, their ‘study group” consists of only 8 people, which is too small to be able to reliably evaluate so many parameters or to draw any far-reaching conclusions. Read the Press Release ...
With regard to a publication alleging a link between ‘brain fogginess’ and probiotics use, IPA Europe cautions that scientists and clinical researchers – both academic and from industry – must remain diligent in their assessment and reporting of safety concerns that may arise from probiotics use and in science communication to non-expert audiences. Read ...
IPA Europe contends that the development of scientifically-based criteria is prerequisite to qualifying a microbial strain as a ‘probiotic’. These criteria are updated as per the latest scientific developments and industry deliberation, to ensure that the probiotic foods industry can consistently create high-quality products that consumers can have confidence in. In developing this voluntary approach, ...
In a joint statement – presented at an event titled “Enabling Innovation in Food/Food Supplements” at the European Parliament today – the Probiotic industry stressed the need for meaningful consumer information in the European Union (EU) on Probiotics? Read more ...